A retrospective pooled analysis of duloxetine safety in 23 983 subjects

ABSTRACT Objective: The safety and tolerability of duloxetine for major depressive disorder (MDD), generalized anxiety disorder (GAD), diabetic peripheral neuropathic pain (DPNP), fibromyalgia, and lower urinary tract disorders (LUTD) (including female stress urinary incontinence [SUI] and other LUT...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current medical research and opinion 2007-01, Vol.23 (1), p.175-184
Hauptverfasser:	Gahimer, James, Wernicke, Joachim, Yalcin, Ilker, Ossanna, Melissa J., Wulster-Radcliffe, Meghan, Viktrup, Lars
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Adverse Drug Reaction Reporting Systems Aged Aged, 80 and over Anxiety Disorders - drug therapy Depressive Disorder, Major - drug therapy Diabetic Neuropathies - drug therapy Diabetic peripheral neuropathic pain Drug safety Duloxetine Duloxetine Hydrochloride Female Fibromyalgia Fibromyalgia - drug therapy Generalized anxiety disorder Humans Major depressive disorder Male Middle Aged Prevalence Retrospective Studies Stress urinary incontinence Thiophenes - adverse effects United States - epidemiology Urinary Incontinence, Stress - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!